clinical implication of induced sputum mucin in severe asthma with airway hypersecretion

clinical implication of induced sputum mucin in severe asthma with airway hypersecretion - clinical implication of induced sputum mucin in severe asthma

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000050456

Enrollment

Registered

2023-02-28

Start date

2023-01-05

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

asthma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.patients with severe asthma 2.patients who coughed up induced sputum 3.Patients who wrote informed consent

Exclusion criteria

Exclusion criteria: 1.patients with respiratory diseases except for asthma 2.patients with pregnant or breast feeding 3.patients who are considered inappropriate by principal investigator

Design outcomes

Primary

Measure	Time frame
The correlations between induced sputum mucin (MUC5AC and MUC5B) levels and asthma control	—

Countries

Japan

Contacts

Public ContactTomoko Tajiri

Nagoya City University Graduate School of Medical Sciences Respiratory Medicine, Allergy and Clinical Immunology

tomokot@med.nagoya-cu.ac.jp052-853-8216

Outcome results